Athyrium Capital Management’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-14,600,444
Closed -$1.26M 4
2023
Q3
$1.26M Hold
14,600,444
1.11% 6
2023
Q2
$8.18M Hold
14,600,444
5.31% 5
2023
Q1
$16.6M Hold
14,600,444
5.96% 4
2022
Q4
$16.4M Hold
14,600,444
6.87% 5
2022
Q3
$30.7M Buy
14,600,444
+6,451,612
+79% +$13.5M 11.48% 4
2022
Q2
$11.1M Hold
8,148,832
4.66% 7
2022
Q1
$13.8M Hold
8,148,832
4.9% 6
2021
Q4
$8.8M Buy
+8,148,832
New +$8.8M 3.14% 5